
German Remedies Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and marketing various medicines for different conditions.
Pharmaceutical company manufacturing and marketing various medicines for different conditions.
German Remedies Pharmaceuticals Private Limited (GRPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 December 2010 and has a history of 14 years and three months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Acme Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 70.00 Cr and a paid-up capital of Rs 66.83 Cr.
The company has closed loans amounting to ₹34.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at German Remedies Pharmaceuticals Private Limited India are Arvind Bothra as CFO and Sanjay Gupta as Company Secretary. Bhavana Doshi, Jyotindra Gor, Rajib Baidya, and Two other members serve as directors at the Company.
Ahmedabad, Gujarat, India
+91-XXXXXXXXXX
U24230GJ2010PTC063425
063425
Private Limited Indian Non-Government Company
29 Dec 2010
02 Aug 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arvind Bothra | CFO | 17-May-2023 | Current |
Sanjay Gupta | Company Secretary | 03-Jan-2020 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajib Baidya ![]() | Director | 29-Mar-2018 | Current |
Bhavana Doshi ![]() | Director | 12-Jun-2020 | Current |
Jyotindra Gor ![]() | Director | 29-Mar-2018 | Current |
Devanand Singh ![]() | Whole-Time Director | 03-Jan-2020 | Current |
Chimanlal Patel ![]() | Director | 29-Mar-2018 | Current |
German Remedies Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.09% increase. The company also saw a substantial fall in profitability, with a 23.31% decrease in profit. The company's net worth Soared by an impressive increase of 20.95%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, German Remedies Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Jyotindra Gor is a mutual person
Jyotindra Gor is a mutual person
Jyotindra Gor is a mutual person
Chimanlal Patel is a mutual person
Arvind Bothra and Sanjay Gupta are mutual person
Bhavana Doshi and Chimanlal Patel are mutual person
₹0
₹34.60 Cr
Date | Lender | Amount | Status |
---|---|---|---|
19 Nov 2014 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.10 Cr | Satisfied |
19 Nov 2014 | The Kalupur Commercial Co-Operative Bank Limited | ₹8.90 Cr | Satisfied |
10 Nov 2014 | The Kalupur Commercial Co-Operative Bank Limited | ₹23.60 Cr | Satisfied |
Unlock and access historical data on people associated with German Remedies Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of German Remedies Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped German Remedies Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
German Remedies Pharmaceuticals Private Limited last Annual general meeting of members was held on 02 Aug 2024 as per latest MCA records.
German Remedies Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Bhavana Sharadchandra Doshi was appointed as a Director was appointed as a Director on 12 Jun 2020 & has been associated with this company since 4 years 10 months .
Devanand Kumar Singh was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 03 Jan 2020 & has been associated with this company since 5 years 3 months .
A charge registered on 10 Nov 2014 via Charge ID 10532652 with The Kalupur Commercial Co-Operative Bank Limited was fully satisfied on 10 Jul 2019.
A charge registered on 19 Nov 2014 via Charge ID 10532653 with The Kalupur Commercial Co-Operative Bank Limited was fully satisfied on 03 Apr 2018.
German Remedies Pharmaceuticals Private Limited was incorporated on 29 Dec 2010.
The authorized share capital of German Remedies Pharmaceuticals Private Limited is ₹ 70.00 Cr and paid-up capital is ₹ 66.83 Cr.
Currently 7 directors are associated with German Remedies Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of German Remedies Pharmaceuticals Private Limited is Pf 61 62 Sanand-Ii Industrial Estate, Tal.: Sanand India, Ahmedabad, Gujarat, 382110.
The corporate identification number (CIN) of German Remedies Pharmaceuticals Private Limited is U24230GJ2010PTC063425 and the company number is 063425 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for German Remedies Pharmaceuticals Private Limited has risen by 10.09%.
The financial reports for the fiscal year 2023 indicates that The net worth of German Remedies Pharmaceuticals Private Limited has experienced an upsurge of 20.95%.
The most recent Balance Sheet for German Remedies Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
DP
AP
NP
SB
AM